EMR vs GSK · P/E 34, rev $4.86B vs P/E 13, $103.31B cap
Emerson Electric Company (EMR) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
GSK does not have a complete income-statement cache yet.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the EMR and GSK stock pages for the full models.
Not investment advice.